Autoimmune diseases co-occurring within individuals and within families: A systematic review

Epidemiology

Volumn 17, Issue 2, 2006, Pages 202-217

  Somers, Emily C ^a,b,c   Thomas, Sara L ^a   Smeeth, Liam ^a   Hall, Andrew J ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b UNIVERSITY OF MICHIGAN   (United States)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOIMMUNE DISEASE; COMORBIDITY; DISEASE ASSOCIATION; FAMILIAL DISEASE; HASHIMOTO DISEASE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MONTE CARLO METHOD; MULTIPLE SCLEROSIS; PREVALENCE; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; SYSTEMATIC REVIEW; TH1 CELL;

ARTHRITIS, RHEUMATOID; AUTOIMMUNE DISEASES; COMORBIDITY; DIABETES MELLITUS, TYPE 1; HASHIMOTO DISEASE; HUMANS; MONTE CARLO METHOD; MULTIPLE SCLEROSIS; PREVALENCE;

EID: 33646764186     PISSN: 10443983     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ede.0000193605.93416.df     Document Type: Review

References (101)

1. Walsh SJ, Rau LM. Autoimmune diseases: a leading cause of death among young and middle-aged women in the United States. Am J Public Health. 2000;90:1463-1466.
2. Skarstein K, Wahren M, Zaura E, et al. Characterization of T cell receptor repertoire and anti-Ro/SSA autoantibodies in relation to sialadenitis of NOD mice. Autoimmunity. 1995;22:9-16.
3. Kouskoff V, Korganow AS, Duchatelle V, et al. Organ-specific disease provoked by systemic autoimmunity. Cell. 1996;87:811-822.
4. Rose N, Mackay I. The Autoimmune Diseases, 3rd ed. San Diego: Academic Press; 1998.
5. Rossini AA, Handler ES, Mordes JP, et al. Human autoimmune diabetes mellitus: lessons from BB rats and NOD mice - caveat emptor. Clin Immunol Immunopathol. 1995;74:2-9.
6. Imai S, Tezuka H, Fujita K. A factor of inducing IgE from a filarial parasite prevents insulin-dependent diabetes mellitus in nonobese diabetic mice. Biochem Biophys Res Commun. 2001;286:1051-1058.
7. Selgrade MK, Lawrence DA, Ullrich SE, et al. Modulation of T-helper cell populations: potential mechanisms of respiratory hypersensitivity and immune suppression. Toxicol Appl Pharmacol. 1997;145:218-229.
8. Becker KG, Simon RM, Bailey-Wilson JE, et al. Clustering of non-major histocompatibility complex susceptibility candidate loci in human autoimmune diseases. Proc Natl Acad Sci U S A. 1998;95:9979-9984.
9. Cooper GS, Miller FW, Pandey JP. The role of genetic factors in autoimmune disease: implications for environmental research. Environ Health Perspect. 1999;107(suppl 5):693-700.
10. Cooper GS, Miller FW, Germolec DR. Occupational exposures and autoimmune diseases. Int Immunopharmacol. 2002;2:303-313.
11. Mosmann TR, Cherwinski H, Bond MW, et al. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol. 1986;136:2348-2357.
12. Sallusto F, Lanzavecchia A, Mackay CR. Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses. Immunol Today. 1998;19:568-574.
13. Kuchroo V, Nicholson L. Cytokines in autoimmune disease. In: Kuchroo V, Sarvetnick N, Hafler D, et al., eds. Cytokines and Autoimmune Diseases. Totowa, NJ: Humana Press; 2002:389-406.
14. Romagnani S. T-cell subsets (Th1, Th2) and cytokines in autoimmunity. In: Rose N, Mackay I, eds. The Autoimmune Diseases. New York: Academic Press; 1998:163-191.
15. Romagnani S. T-cell subsets (Th1 versus Th2). Ann Allergy Asthma Immunol. 2000;85:9-18.
16. Silman AJ. Rheumatoid arthritis. In: Silman AJ, Hochberg MC, eds. Epidemiology of the Rheumatic Diseases, 2nd ed. Oxford: Oxford University Press; 2001:31-71.
17. Sloka S. Observations on recent studies showing increased co-occurrence of autoimmune diseases. J Autoimmunity. 2002;18:251-257.
18. Monaco F. Classification of thyroid diseases: suggestions for a revision. J Clin Endocrinol Metab. 2003;88:1428-1432.
19. Jacobson DL, Gange SJ, Rose NR, et al. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol. 1997;84:223-243.
20. Linos A, Worthington JW, Palumbo PJ, et al. Occurrence of Hashimoto's thyroiditis and diabetes mellitus in patients with rheumatoid arthritis. J Chronic Dis. 1980;33:73-77.
21. Panczel P, Falus A, Meretey K, et al. [Association between cumulative familial incidence of type I diabetes and rheumatoid arthritis.] Orvosi Hetilap. 1985;126:1281-1284, 1287-1289.
22. Thomas DJ, Young A, Gorsuch AN, et al. Evidence for an association between rheumatoid arthritis and autoimmune endocrine disease. Ann Rheum Dis. 1983;42:297-300.
23. Hakala M, Ilonen J, Reijonen H, et al. No association between rheumatoid arthritis and insulin dependent diabetes mellitus: an epidemiologic and immunogenetic study. J Rheumatol. 1992;19:856-858.
24. Vaidya B, Pearce SH, Charlton S, et al. An association between the CTLA4 exon 1 polymorphism and early rheumatoid arthritis with autoimmune endocrinopathies. Rheumatology. 2002;41:180-183.
25. Becker K, Titus J, Woolner LB, et al. Thyroiditis and rheumatoid arthritis. Proc Mayo Clin. 1963:38:125.
26. Herrmann F, Hambsch K, Muller P, et al. [Incidence of goiter and thyroiditis in chronic inflammatory rheumatism]. Zeitschrift fur die Gesamte Innere Medizin und Ihre Grenzgebiete. 1990;45:52-55.
27. Shiroky JB, Cohen M, Ballachey ML, et al. Thyroid dysfunction in rheumatoid arthritis: a controlled prospective survey. Ann Rheum Dis. 1993;52:454-456.
28. Pongratz R, Buchinger W, Semlitsch G, et al. [Increased occurrence of autoimmune thyroiditis in patients with chronic rheumatoid arthritis]. Acta Med Austriaca. 2000;27:58-60.
29. Benamour S, Zeroual B, Fares L, et al. [Rheumatoid arthritis in Morocco. Apropos of 404 observations]. Revue du Rhumatisme et des Maladies Osteo Articulaires. 1992;59:801-807.
30. Chan AT, Al-Saffar Z, Bucknall RC. Thyroid disease in systemic lupus erythematosus and rheumatoid arthritis. Rheumatology. 2001;40:353-354.
31. Alpigiani MG, Cerboni M, Bertini I, et al. Endocrine autoimmunity in young patients with juvenile chronic arthritis. Clin Exp Rheumatol. 2002;20:565-568.
32. Gilani BB, MacGillivray MH, Voorhess ML, et al. Thyroid hormone abnormalities at diagnosis of insulin-dependent diabetes mellitus in children. J Pediatr. 1984;105:218-222.
33. Betterle C, Zanette F, Pedini B, et al. Clinical and subclinical organ-specific autoimmune manifestations in type 1 (insulin-dependent) diabetic patients and their first-degree relatives. Diabetologia. 1984;26:431-436.
34. Pavia Sesma C, Valls Tolosa C, Eighian Baho B, et al. [Thyroid autoimmunity in type I (insulin dependent) diabetes mellitus]. Anales Espanoles de Pediatria. 1989;31:523-527.
35. McKenna MJ, Herskowitz R, Wolfsdorf JI. Screening for thyroid disease in children with IDDM. Diabetes Care. 1990;13:801-803.
36. Burek CL, Rose NR, Guire KE, et al. Thyroid autoantibodies in black and in white children and adolescents with type 1 diabetes mellitus and their first degree relatives. Autoimmunity. 1990;7:157-167.
37. Kontiainen S, Schlenzka A, Koskimies S, et al. Autoantibodies and autoimmune diseases in young diabetics. Diabetes Res. 1990;13:151-156.
38. Gruneiro De Papendieck L, Chiesa A, Trifone L, et al. Thyroid disorders in children and adolescents with insulin-dependent diabetes mellitus. Acta Pediatr Esp. 1995;53:362-365.
39. Gamba S, Carlini M, Blatto A, et al. Frequency of autoimmune thyroid disease in adult patients with insulin-dependent diabetes mellitus. Giornale Italiano di Diabetologia. 1994;14:101-105.
40. McCanlies E, O'Leary LA, Foley TP, et al. Hashimoto's thyroiditis and insulin-dependent diabetes mellitus: differences among individuals with and without abnormal thyroid function. J Clin Endocrinol Metab. 1998;83:1548-1551.
41. Darendeliler FF, Kadioglu A, Bas F, et al. Thyroid ultrasound in IDDM. J Pediatr Endocrinol. 1994;7:33-37.
42. Radetti G, Paganini C, Gentili L, et al. Frequency of Hashimoto's thyroiditis in children with type 1 diabetes mellitus. Acta Diabetol. 1995;32:121-124.
43. Chuang LM, Wu HP, Chang CC, et al. HLA DRB1/DQA1/DQB1 haplotype determines thyroid autoimmunity in patients with insulin-dependent diabetes mellitus. Clin Endocrinol (Oxf). 1996;45:631-636.
44. Lorini R, d'Annunzio G, Vitali L, et al. IDDM and autoimmune thyroid disease in the pediatric age group. J Pediatr Endocrinol Metab. 1996;9:89-94.
45. Hansen D, Bennedbaek FN, Hansen LK, et al. Thyroid function, morphology and autoimmunity in young patients with insulin-dependent diabetes mellitus. Eur J Endocrinol. 1999;140:512-518.
46. Roldan MB, Alonso M, Barrio R. Thyroid autoimmunity in children and adolescents with type 1 diabetes mellitus. Diabetes Nutr Metab. 1999;12:27-31.
47. Hanukoglu A, Mizrachi A, Dalal I, et al. Extrapancreatic autoimmune manifestations in type 1 diabetes patients and their first-degree relatives: a multicenter study. Diabetes Care. 2003;26:1235-1240.
48. Sanchez-Lugo F. Prevalence of thyroid autoimmunity in insulin dependent diabetes mellitus in the Bayamon region. Boletin Asociacion Medica de Puerto Rico. 1991;83:54-57.
49. Tsai WY, Lee JS. Thyroid disease in Chinese children with IDDM. Diabetes Care. 1993;16:1314-1315.
50. Wong GW. Absence of thyroid disease in Chinese children with IDDM. Diabetes Care. 1993;16:404-405.
51. Prina Cerai LM, Weber G, Meschi F, et al. Prevalence of thyroid autoantibodies and thyroid autoimmune disease in diabetic children and adolescents. Diabetes Care. 1994;17:782-783.
52. Molina Lacasa A, Fernandez Castaner M, Perez Maraver M, et al. [Autoimmune thyroid pathology in recently diagnosed diabetes mellitus type 1]. Rev Clin Esp. 1998;198:818-821.
53. Fernandez-Castaner M, Molina A, Lopez-Jimenez L, et al. Clinical presentation and early course of type 1 diabetes in patients with and without thyroid autoimmunity. Diabetes Care. 1999;22:377-381.
54. Park YS, Kim TW, Kim WB, et al. Increased prevalence of autoimmune thyroid disease in patients with type 1 diabetes. Korean J Intern Med. 2000;15:202-210.
55. Menon PS, Vaidyanathan B, Kaur M. Autoimmune thyroid disease in Indian children with type 1 diabetes mellitus. J Pediatr Endocrinol. 2001;14:279-286.
56. Radaideh A, El-Khateeb M, Batieha AM, et al. Thyroid function and thyroid autoimmunity in patients with type 1 diabetes mellitus. Saudi Med J. 2003;24:352-355.
57. Umpierrez GE, Latif KA, Murphy MB, et al. Thyroid dysfunction in patients with type 1 diabetes: a longitudinal study. Diabetes Care. 2003;26:1181-1185.
58. Kordonouri O, Meyer K, Egerer K, et al. Prevalence of 20S proteasome, anti-nuclear and thyroid antibodies in young patients at onset of type 1 diabetes mellitus and the risk of autoimmune thyroiditis. J Pediatr Endocrinol Metab. 2004;17:975-981.
59. Wynn DR, Rodriguez M, O'Fallon WM, et al. A reappraisal of the epidemiology of multiple sclerosis in Olmsted County, Minnesota. Neurology. 1990;40:780-786.
60. Baker HW, Balla JI, Burger HG, et al. Multiple sclerosis and autoimmune diseases. Aust N Z J Med. 1972;2:256-260.
61. Midgard R, Gronning M, Riise T, et al. Multiple sclerosis and chronic inflammatory diseases. A case-control study. Acta Neurol Scand. 1996;93:322-328.
62. De Keyser J. Autoimmunity in multiple sclerosis. Neurology. 1988;38:371-374.
63. Marrosu MG, Cocco E, Lai M, et al. Patients with multiple sclerosis and risk of type 1 diabetes mellitus in Sardinia, Italy: a cohort study. Lancet. 2002;359:1461-1465.
64. Broadley SA, Deans J, Sawcer SJ, et al. Autoimmune disease in first-degree relatives of patients with multiple sclerosis. A UK survey. Brain. 2000;123:1102-1111.
65. Heinzlef O, Alamowitch S, Sazdovitch V, et al. Autoimmune diseases in families of French patients with multiple sclerosis. Acta Neurol Scand. 2000;101:36-40.
66. Becker K, Titus J, Woolner L, et al. Significance of morphologic thyroiditis. Ann Intern Med. 1965;62:1134-1138.
67. Furszyfer J, Kurland LT, McConahey WM, et al. Epidemiologic aspects of Hashimoto's thyroiditis and Graves' disease in Rochester, Minnesota (1935-1967), with special reference to temporal trends. Metabolism. 1972;21:197-204.
68. Mulhern LM, Masi AT, Shulman LE. Hashimoto's disease. A search for associated disorders in 170 clinically detected cases. Lancet. 1966;2:508-511.
69. Becker K, Ferguson R, McConahey W. The connective-tissue diseases and symptoms associated with Hashimoto's thyroiditis. N Engl J Med. 1963:268:277-280.
70. Buchanan W, Grooks J, Alexander W, et al. Association of Hashimoto's thyroiditis and rheumatoid arthritis. Lancet. 1961;245.
71. Masi A, WH H, Hahn B, et al. Hashimoto's disease. A clinicopathological study with matched controls. Lack of significant associations with other 'autoimmune' disorders. Lancet. 1965;1:123-126.
72. Lin JP, Cash JM, Doyle SZ, et al. Familial clustering of rheumatoid arthritis with other autoimmune diseases. Hum Genet. 1998;103:475-482.
73. Prahalad S, Shear ES, Thompson SD, et al. Increased prevalence of familial autoimmunity in simplex and multiplex families with juvenile rheumatoid arthritis. Arthritis Rheum. 2002;46:1851-1856.
74. Davidson A, Diamond B. Autoimmune diseases. N Engl J Med. 2001;345:340-350.
75. Niwa Y, Sakane T, Kanoh T, et al. Transient autoantibodies with elevated complement levels in common viral diseases. J Clin Lab Immunol. 1984;13:183-188.
76. Hansen KE, Arnason J, Bridges AJ. Autoantibodies and common viral illnesses. Semin Arthritis Rheum. 1998;27:263-271.
77. Hawkins BR, Cheah PS, Dawkins RL, et al. Diagnostic significance of thyroid microsomal antibodies in randomly selected population. Lancet. 1980;2:1057-1059.
78. Vanderpump M, Tunbridge W. The epidemiology of autoimmune thyroid disease. In: Volpe R, ed. Autoimmune Endocrinopathies. Totowa, NJ: Humana Press; 1999:141-162.
79. Ropes MW, Bennett GA, Cobb S, et al. Proposed diagnostic criteria for rheumatoid arthritis. Ann Rheum Dis. 1957;16:118-123.
80. Palumbo PJ, Elveback LR, Chu CP, et al. Diabetes mellitus: incidence, prevalence, survivorship, and causes of death in Rochester, Minnesota, 1945-1970. Diabetes. 1976;25:566-573.
81. Furszyfer J, Kurland LT, Woolner LB, et al. Hashimoto's thyroiditis in Olmsted County, Minnesota, 1935 through 1967. Mayo Clin Proc. 1970;45:586-596.
82. Ropes M, Bennett G, Cobb S, et al. 1958 revision of diagnostic criteria for rheumatoid arthritis. Bull Rheum Dis. 1958;9:175-176.
83. National Diabetes Data Group.Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes. 1979;28:1039-1057.
84. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315-324.
85. Committee of American Rheumatism Association. Primer on rheumatic diseases. Part III. JAMA. 1959;171:1680-1691.
86. Altman R, Asch E, Bloch D, et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum. 1986;29:1039-1049.
87. Altman R, Alarcon G, Appelrouth D, et al. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hand. Arthritis Rheum. 1990;33:1601-1610.
88. Altman R, Alarcon G, Appelrouth D, et al. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip. Arthritis Rheum. 1991;34:505-514.
89. Wood P. Special Meeting on: nomenclature and classification of arthritis in children. In: Munthe E, ed. The Care of Rheumatic Children. Basel: EULAR Publisher; 1987:47-50.
90. Fisher DA, Oddie TH, Johnson DE, et al. The diagnosis of Hashimoto's thyroiditis. J Clin Endocrinol Metab. 1975;40:795-801.
91. World Health Organization.Diabetes mellitus. Report of a WHO Study Group. World Health Organ Tech Rep Ser. 1985;727:1-113.
92. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus.Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 1999;22:85-19.
93. Hollowell JG, Staehling NW, Flanders WD, et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2002;87:489-499.
94. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care.1997;20:1183-1197.
95. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol. 1983;13:227-231.
96. Wood PHN. Epidemiology of rheumatic disorders. In: Scott JT, ed. Copeman's Textbook of the Rheumatic Diseases. Edinburgh: Churchill Livingstone; 1978:25-60.
97. Christy M, Deckert T, Nerup J. Immunity and autoimmunity in diabetes mellitus. Clin Endocrinol Metab. 1977;6:305-332.
98. Tunbridge WM, Evered DC, Hall R, et al. The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxf). 1977;7:481-493.
99. Bauer H. IMAB enquete concerning the diagnostic criteria for MS. In: Bauer H, Poser S, Ritter G, eds. Progress in Multiple Sclerosis Research. Heidelberg: Springer; 1980:555-563.
100. Kellgren J, Lawrence J. Rheumatoid arthritis in a population sample. Ann Rheum Dis. 1956;15:1-11.
101. Cassidy JT, Levinson JE, Bass JC, et al. A study of classification criteria for a diagnosis of juvenile rheumatoid arthritis. Arthritis Rheum. 1986;29:274-281.